Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,122 total articles
John D. Couling, Senior Vice President of Entertainment at Dolby Laboratories, Inc. (NASDAQ:DLB), executed a significant stock transaction on July 1, 2026, selling 7,667 shares of the company's Class A Common Stock. The sale, valued at approximately $407,894, follows the immediate exercise of employee stock options for an identical number of shares…
Lynton Nicholas Hollmeyer, Cardlytics Inc.'s Chief Legal & Privacy Officer, executed a sale of 2,151 shares on July 2, 2026, valued at $9,453. The transaction was necessitated by tax withholding requirements following the vesting of restricted stock units. This activity occurs against a backdrop of stock price volatility and a recent quarterly earn…
Omada Health Inc. CEO Sean P. Duffy executed a series of stock transactions on July 1, 2026, selling 25,886 shares worth $587,222 under a pre-established 10b5-1 plan. The sale coincides with the company's Q1 2026 earnings beat, revenue growth of 42%, and recent board elections. Duffy simultaneously exercised stock options to acquire an equal number…
K. Charles Janac, President and Chief Executive Officer of Arteris, Inc. (NASDAQ:AIP), executed a series of stock transactions on July 2, 2026, totaling approximately $7.42 million. The transactions comprised both direct sales to cover tax liabilities and indirect dispositions through a pre-arranged trading plan. Despite the executive's sales, Arte…
JELD-WEN Holding, Inc. (NYSE: JELD) is navigating a period of significant financial strain, marked by a recent stock sale from its Executive Vice President and Chief Financial Officer, Samantha Stoddard. The transaction, executed to cover tax obligations from restricted stock unit vesting, occurs against a backdrop of deteriorating stock performanc…
Cuentas Inc. (NASDAQ:CUEN) Chief Executive Officer Maimon Shalom Arik executed a series of open market purchases totaling $2,011 in the company's common stock earlier this month. The transactions, which occurred on July 1 and July 2, 2026, involved the acquisition of 5,200 shares at prices ranging between $0.35 and $0.45 per share. This insider act…
Paul L. Alpern, Vice President and General Counsel at Arteris, Inc. (NASDAQ:AIP), executed a mandatory sale of 3,648 shares on July 2, 2026, generating $141,461. The transaction, structured as a 'sell to cover' to satisfy tax liabilities from restricted stock unit releases, leaves Mr. Alpern with a direct holding of 76,736 shares. This activity occ…
Nicholas B. Hawkins, Vice President and Chief Financial Officer of Arteris, Inc. (NASDAQ:AIP), executed a mandatory stock sale on July 2, 2026, to satisfy tax liabilities associated with the release of restricted stock units. The transaction involved the disposition of 5,377 shares at $38.7779 per share, totaling $208,508. This 'sell to cover' even…
SEACOR Marine Holdings Inc. (NASDAQ: SMHI) Executive Vice President and Chief Financial Officer Jesus Llorca has executed a sale of 1,386 shares of the company's common stock. The transaction, valued at $11,101, was carried out automatically under a Rule 10b5-1 trading plan established in March 2026. Following this divestment, Llorca retains direct…
Mark Lin, Semtech Corp's Executive Vice President and Chief Financial Officer, executed a series of transactions on July 1, 2026, involving both the sale and acquisition of the company's stock. The sales were conducted under a pre-established Rule 10b5-1 trading plan and to cover tax liabilities. Despite recent share price volatility, Semtech's fis…
Andrew Reardon, Chief Legal Officer and Secretary at Ligand Pharmaceuticals Inc., sold 5,000 shares of common stock on July 1, 2026, generating $1,566,376 under a pre-arranged Rule 10b5-1 trading plan. The transaction occurred as Ligand's stock traded near its 52-week high of $320.99, with shares valued at $320.42 according to recent analysis. Prio…
Michael A. Pisetsky, Senior Vice President of Operations & Administration and Chief Legal Officer at SI-BONE, Inc. (NASDAQ:SIBN), executed a sale of 3,134 shares on July 2, 2026, totaling $52,375. The transaction, priced between $16.6992 and $16.86 per share, was necessitated by tax withholding requirements linked to restricted stock unit vesting r…
Ibotta Inc. (NASDAQ: IBTA) CEO and President Bryan Leach executed a series of share transactions totaling approximately $994,000 in early July 2026. These moves, structured under a pre-established Rule 10b5-1 trading plan, involved the sale of 28,231 Class A shares and the concurrent exercise of stock options for 21,895 shares. The transactions hig…
EverCommerce Inc. (NASDAQ: EVCM) Chief Executive Officer Eric Remer executed a sale of 18,950 shares on July 2, 2026, totaling $193,369. The transaction was conducted under a pre-arranged Rule 10b5-1 trading plan. This move follows a period of stock depreciation and coincides with the company's recently reported first-quarter financial results, whi…
Xometry Inc. (NASDAQ: XMTR) director Randolph Altschuler executed an automatic sale of 5,722 Class A Common Stock shares on July 2, 2026, totaling $533,869. The transaction, processed under a pre-established Rule 10b5-1 plan, was primarily intended to satisfy tax withholding requirements linked to restricted stock unit vesting. Following the sale, …
SI-BONE, Inc. (NASDAQ:SIBN) Chief Financial Officer Anshul Maheshwari completed a series of mandatory share sales on July 2, 2026, totaling $55,626 in value. The transactions, necessitated by tax withholding requirements tied to the vesting of restricted stock units, reduced his direct holdings but left him with a substantial position of 256,560 sh…
Immunovant CEO Eric Venker executed a $118,980 sale of company stock on July 2, 2026, following the settlement of Capped Value Appreciation Rights. The transaction, mandated to cover tax obligations, occurred as IMVT trades near a 52-week high of $39.28, despite analysts flagging the stock as overvalued relative to fair value estimates. The sale fo…
Edward J. Dulac III, serving as Executive Vice President and Chief Financial Officer at Intellia Therapeutics, Inc. (NASDAQ: NTLA), has executed a sale of company equity totaling $84,186. The transaction involved the disposition of 4,677 common shares on July 2, 2026, as documented in a Form 4 filing submitted to the Securities and Exchange Commiss…
Jason Phipps, Senior Vice President of Global Sales and Marketing at Ciena Corporation (NASDAQ:CIEN), executed a sale of 2,629 shares of common stock on July 1, 2026, totaling approximately $1,225,639. The transaction, conducted at $466.20 per share, was carried out under a Rule 10b5-1 trading plan originally established on October 9, 2024, and lat…
Jon Blotner, President of Commercial & Operations at Wayfair Inc., executed a sale of 5,925 shares of Class A Common Stock on July 2, 2026, totaling $570,518. The transaction was conducted under a Rule 10b5-1 trading plan established in August 2025. This sale follows a significant acquisition of restricted stock units (RSUs) on July 1, 2026, which …
BETA Technologies CEO Kyle Clark executed two separate sales of Class A common stock totaling $530,065 through a pre-established 10b5-1 trading plan on July 1 and July 2, 2026. The transactions, facilitated via The Godric’s Hollow Trust, come as the company processes Q1 2026 results that featured a wider-than-anticipated loss alongside revenue that…
Nealesh D. Shah, Senior Vice President and Chief Financial Officer at Kosmos Energy Ltd. (NASDAQ:KOS), executed a sale of company stock following the vesting of restricted share units. The transaction, filed with the Securities and Exchange Commission, highlights routine equity compensation activity against a backdrop of significant year-to-date sh…
Steve Pakola, REGENXBIO Inc.'s Chief Medical Officer, executed a sale of 2,161 shares of common stock valued at $29,476 on July 2, 2026. The transaction was part of a Rule 10b5-1 trading plan and involved the exercise of stock options at $7.86 per share. The sale occurred as the company announces significant progress in its clinical pipeline, inclu…
Frederick R. Wilson, a director at Coinbase Global, Inc. (NASDAQ: COIN), executed a sale of 10,000 shares of the company's Class A Common Stock on July 1, 2026. The transaction, valued at approximately $1,590,926, was conducted under a Rule 10b5-1 trading plan adopted earlier in the year. The shares were sold at prices ranging from $146.53 to $163.…
Andrew J Briggs, a director at Farmers & Merchants Bancorp Inc (NASDAQ:FMAO), executed two separate sales of the bank's common stock totaling $186,600, according to a recent Securities and Exchange Commission filing. The transactions occurred on July 2 and July 6, 2026, with Mr. Briggs disposing of 3,000 shares each time at prices of $31.53 and $30…
